4.8 Article

Tracheal Allotransplantation after Withdrawal of Immunosuppressive Therapy

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 362, 期 2, 页码 138-145

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa0810653

关键词

-

资金

  1. GlaxoSmithKline Belgium
  2. AstraZeneca Belgium

向作者/读者索取更多资源

Reconstruction of long-segment tracheal defects requires a vascularized allograft. We report successful tracheal allotransplantation after indirect revascularization of the graft in a heterotopic position. Immunosuppressive therapy was administered before the operation, and the tracheal allograft was wrapped in the recipient's forearm fascia. Once revascularization was achieved, the mucosal lining was replaced progressively with buccal mucosa from the recipient. At 4 months, the tracheal chimera was fully lined with mucosa, which consisted of respiratory epithelium from the donor and buccal mucosa from the recipient. After withdrawal of immunosuppressive therapy, the tracheal allograft was moved to its correct anatomical position with an intact blood supply. No treatment-limiting adverse effects occurred.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据